Clinical Trial Update: Bioavailability of Variably Aged MK-0974 Tablets (MK-0974-038)(COMPLETED) [Phase 1]

View source ↗

Summary

A Phase 1 pharmacokinetic study evaluated the bioavailability of variably aged MK-0974 tablets (telcagepant) in migraine, and the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Migraine

Drugs mentioned

• Telcagepant (telcagepant)

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Migraine | Phase 1 | Status: COMPLETED